Victory Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Victory Capital Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,971	Closed	-$202K	–	2897
2021 Q2	$202K	Sell	5,971 -1,585,090	-100%	-$40.4M	﹤0.01%	2526
2021 Q1	$37.2M	Buy	1,591,061 +417,813	+36%	+$12.7M	0.04%	671
2020 Q4	$33.8M	Buy	1,173,248 +188,826	+19%	+$4.75M	0.04%	667
2020 Q3	$19.9M	Buy	984,422 +220,814	+29%	+$5.39M	0.03%	801
2020 Q2	$22.9M	Sell	763,608 -544,962	-42%	-$19.6M	0.03%	718
2020 Q1	$41.1M	Buy	1,308,570 +1,306,321	+58,085%	+$45.4M	0.03%	645
2019 Q4	$106K	Buy	2,249 +716	+47%	+$20.7K	﹤0.01%	2523
2019 Q3	$10K	Buy	+1,533	New	+$12.8K	﹤0.01%	3284
2018 Q4	–	Sell	-142,230	Closed	-$957K	–	1830
2018 Q3	$957K	Buy	+142,230	New	+$1.36M	﹤0.01%	1290

Victory Capital Management's CNST Position: Q3 2021 in Review

Victory Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 5,971 shares — an estimated $202K sold.

Victory Capital Management first reported a position in CNST in Q3 2018 and held it in 9 quarters. The position peaked at $41.1M in Q1 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Victory Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Victory Capital Management sold 5,971 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $202K.
Victory Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 9 quarters.
Victory Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $41.1M in Q1 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Victory Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.